Janssen

Latest News

What You Need to Know About Johnson & Johnson's 2021 Second-Quarter Earnings

Check out this infographic breakdown of the company’s second-quarter 2021 performance, with key highlights from its Pharmaceutical, Consumer Health and Medical Device businesses.

ON NOW

Personal Stories

"1.5 Million Children Are Living With HIV in Sub-Saharan Africa. I'm One of the Doctors Treating These Young Patients Every Day"

A relaunched Johnson & Johnson partnership will help ensure that many young patients get lifesaving access to HIV medicines. Meet a doctor in Kenya who explains why the program is so crucial.

ON NOW

Latest News

Johnson & Johnson Ranks #4 on Fortune’s Return on Leadership List

For more than a century, Johnson & Johnson has used a core set of values to help build its business. Now, that sense of purpose has landed it on the Fortune ROL100, a new ranking of corporate leadership.

ON NOW

Latest News

5 Ways Johnson & Johnson Is Working to Improve the Well-Being of the World by 2025

Johnson & Johnson's 2020 Health for Humanity Report details the progress it's made in the past five years in driving sustainable social, environmental and economic change around the globe. Now the company's looking ahead to the next five.

ON NOW

Members of a Johnson & Johnson HIV prevention program in South Africa

Innovation

How Johnson & Johnson Has Pioneered in the Battle Against HIV/AIDS

On the 40th anniversary of what would become the first AIDS diagnosis, we look at the groundbreaking strides the company has made—and continues to make—toward a world without the disease.

ON NOW

Innovation

What to Know About HDFN—a Serious Blood Disorder in Babies—Including a Possible New Treatment

Severe cases of hemolytic disease of the fetus and newborn can be deadly in infants. That's why Johnson & Johnson is passionate about investigating a promising option for treating the disorder.

ON NOW

Innovation

The Quest to Help Patients with a Deadly Type of Lung Cancer

Despite obstacles and setbacks, these researchers vowed to never give up working to develop a new treatment for non-small cell lung cancer. As the drug receives FDA approval, they share their journey.

ON NOW

Latest News

What You Need to Know About Johnson & Johnson's 2021 First-Quarter Earnings

Check out this infographic breakdown of the company’s first-quarter 2021 performance, with key highlights from its consumer, pharmaceutical and medical devices businesses.

ON NOW

Health & Wellness

4 Things Scientists Now Know About Autoimmune Diseases in Kids

Two experts in the field share the latest understanding and research into conditions like pediatric plaque psoriasis, juvenile idiopathic arthritis and pediatric active psoriatic arthritis—diseases that afflict children and can have long-term damaging effects into adulthood if not properly treated.

ON NOW

Image of young child with skeleton overlay

Latest News

Johnson & Johnson Chairman and CEO Appears at the White House to Discuss the Company's Collaboration with Merck and Future Vaccine Production

Learn more about the event, Johnson & Johnson's historic collaboration with Merck—and watch a video that chronicles the progress that the company has made since last March in the fight against COVID-19.

ON NOW

Our Heritage

6 Trailblazing Johnson & Johnson Scientists Past and Present

We're spotlighting three of the company's pioneering early female scientists—and their modern-day counterparts, who are not only innovating in the lab, but also paving the way for the next generation of powerhouse women.

ON NOW

Innovation

From Lab to Vaccine Vial: The Historic Manufacturing Journey of Johnson & Johnson's Janssen COVID-19 Vaccine

As the U.S. government announces an agreement between Johnson & Johnson and Merck to collaborate on vaccine production, we trace all the steps it takes—from growing cells in a bioreactor to prepping palettes with high-tech track-and-trace technology—to develop and manufacture a vaccine during a pandemic.

ON NOW

Health & Wellness

4 Things We Now Know About the Rare Disease AL Amyloidosis

Imagine having a disease that many doctors have never seen before. That's what Marty Verel experienced when he was told he had AL amyloidosis—and it's what hematologist Brendan Weiss, M.D., is determined to help change. For Amyloidosis Awareness Month, Dr. Weiss shares what he's learned studying the rare disease.

ON NOW

Latest News

A Message from Chairman and CEO Alex Gorsky About the Emergency Use Authorization of Johnson & Johnson's Janssen COVID-19 Vaccine

The company leader shares the latest news about the U.S. Food and Drug Administration's decision about the single-shot Janssen COVID-19 vaccine.

ON NOW

Latest News

8 Things to Know About Johnson & Johnson's Janssen COVID-19 Vaccine

As the company announces that its single-dose Janssen COVID-19 Vaccine has been granted Emergency Use Authorization by the U.S. Food and Drug Administration, here are some key facts about how it works (hint: it involves an inactivated common cold virus), how it has been studied, how it would be transported—and more.

ON NOW

Internet Explorer is no longer supported by this website.

Janssen